吴标基于"肺脾同治"理论治疗肺癌经验总结OA
Summary of WU Biao's Experience in Treatment of Lung Cancer Based on Theory of Treating Lung and Spleen Together
吴标教授认为肺脾同治为肺癌治疗的关键.其中,宗气不足为先决条件,痰湿内阻为始动因素,痰瘀互结为终末结局.治疗上以补益宗气、化痰止咳、通络化瘀为基础;临床上根据肺癌表现不同选用六君子汤加减、清金化痰汤加减以及血府逐瘀汤加减;注重肺脾同治、标本兼顾.并附验案加以阐明.
Professor WU Biao believes that lung-spleen homoeopathy is the key to lung cancer treatment.Among them,in-sufficiency of Zongqi is the prerequisite,phlegm-dampness internal obstruction is the initiating factor,and phlegm-blood stasis inter-conjugation is the end result.The treatment is based on tonifying Zongqi,resolving phlegm and reliving cough,and clearing the meridians and removing blood stasis.Clinically,according to the different manifestations of lung cancer,Modified Liujunzi De-coction(六君子汤加减),Modified Qingjin Huatan Decoction(清金化痰汤加减)and Modified Xuefu Zhuyu Decoction(血府逐瘀汤加减)are used,focusing on treating lung and spleen together and taking into account both the symptoms and the root cause.In addition,the medical records were attached to illustrate.
赵福成;刘振洲;赵志鑫;任伟华;贾奎
河南医药大学第一附属医院,河南新乡 453100河南医药大学第一附属医院,河南新乡 453100辉县市中医院,河南新乡 453600河南医药大学第一附属医院,河南新乡 453100河南医药大学第一附属医院,河南新乡 453100
医药卫生
肺脾同治肺癌经验总结
lung-spleen homoeopathylung cancerexperience summary
《辽宁中医杂志》 2026 (9)
45-48,4
第七批全国老中医药专家学术继承工作项目(国中医药人教函[2021]272号)河南省中医药科学研究专项课题(2024ZY3086)河南省中医药重点学科建设项目(豫卫中医[2023]号)
评论